retatrutide mechanism glp-1 gip glucagon triple agonist Agonists for Diabetes: Why May Be the Missing Piece Retatrutide Explained: The Triple Agonist

Weight and Glycemic Control in Type 2 Diabetes TRIUMPH-2 (NCT05929079) enrolled 1,152 adults with obesity or overweight and type 2 diabetes, a population that often experiences greater difficulty achieving substantial weight loss

It is the first FDA approved medication to treat moderate to severe binge eating disorder

Endotoxin Testing per USP Bacterial endotoxin is measured on every released lot following the LAL procedure described in USP

These studies highlighted the potential of their method for the successful regeneration of damaged articular cartilage

See a healthcare provider immediately if you experience: An inability to eat Persistent or severe nausea that impacts your daily life Signs of dehydration (extreme thirst, dizziness, dry mouth, peeing less often) If your nausea is severe, consult with your prescribing physician or your GI team